COT Polyclonal Antibody

Alias:MAP3K8;COT;ESTF;Mitogen-activated protein kinase kinase kinase 8;Cancer Osaka thyroid oncogene;Proto-oncogene c-Cot;Serine/threonine-protein kinase cot;Tumor progression locus 2;TPL-2

CatalogNo:HJRLT1066

Specifications

50μL;100μL

Delivery date

Spot

Target

COT

Reactivity

Human,Mouse,Rat

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

60kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:40000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human COT. AA range:256-305

Specificity

COT Polyclonal Antibody detects endogenous levels of COT protein.

Gene name

MAP3K8

Protein name

Mitogen-activated protein kinase kinase kinase 8

Organism-1

Human